Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma.
Goff SL, Morgan RA, Yang JC, Sherry RM, Robbins PF, Restifo NP, Feldman SA, Lu YC, Lu L, Zheng Z, Xi L, Epstein M, McIntyre LS, Malekzadeh P, Raffeld M, Fine HA, Rosenberg SA. Goff SL, et al. Among authors: fine ha. J Immunother. 2019 May;42(4):126-135. doi: 10.1097/CJI.0000000000000260. J Immunother. 2019. PMID: 30882547 Free PMC article.
Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells.
Beard RE, Zheng Z, Lagisetty KH, Burns WR, Tran E, Hewitt SM, Abate-Daga D, Rosati SF, Fine HA, Ferrone S, Rosenberg SA, Morgan RA. Beard RE, et al. Among authors: fine ha. J Immunother Cancer. 2014 Aug 19;2:25. doi: 10.1186/2051-1426-2-25. eCollection 2014. J Immunother Cancer. 2014. PMID: 25197555 Free PMC article.
Glioblastoma: Not Just Another Cancer.
Fine HA. Fine HA. Cancer Discov. 2024 Apr 4;14(4):648-652. doi: 10.1158/2159-8290.CD-23-1498. Cancer Discov. 2024. PMID: 38571415
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).
Iwamoto FM, Lamborn KR, Robins HI, Mehta MP, Chang SM, Butowski NA, Deangelis LM, Abrey LE, Zhang WT, Prados MD, Fine HA. Iwamoto FM, et al. Among authors: fine ha. Neuro Oncol. 2010 Aug;12(8):855-61. doi: 10.1093/neuonc/noq025. Epub 2010 Mar 3. Neuro Oncol. 2010. PMID: 20200024 Free PMC article. Clinical Trial.
Continuous daily sunitinib for recurrent glioblastoma.
Kreisl TN, Smith P, Sul J, Salgado C, Iwamoto FM, Shih JH, Fine HA. Kreisl TN, et al. Among authors: fine ha. J Neurooncol. 2013 Jan;111(1):41-8. doi: 10.1007/s11060-012-0988-z. Epub 2012 Oct 20. J Neurooncol. 2013. PMID: 23086433 Clinical Trial.
229 results